This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pugachev, K. V.
Right arrow Articles by Monath, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pugachev, K. V.
Right arrow Articles by Monath, T. P.

 Previous Article  |  Next Article 

Journal of Virology, January 2004, p. 1032-1038, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.1032-1038.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

High Fidelity of Yellow Fever Virus RNA Polymerase

Konstantin V. Pugachev, Farshad Guirakhoo, Simeon W. Ocran, Fred Mitchell, Megan Parsons, Caroline Penal, Soheila Girakhoo, Svetlana O. Pougatcheva, Juan Arroyo,{dagger} Dennis W. Trent, and Thomas P. Monath*

Acambis, Inc., Cambridge, Massachusetts 02139

Received 4 June 2003/ Accepted 3 October 2003

Three consecutive plaque purifications of four chimeric yellow fever virus-dengue virus (ChimeriVax-DEN) vaccine candidates against dengue virus types 1 to 4 were performed. The genome of each candidate was sequenced by the consensus approach after plaque purification and additional passages in cell culture. Our data suggest that the nucleotide sequence error rate for SP6 RNA polymerase used in the in vitro transcription step to initiate virus replication was as high as 1.34 x 10-4 per copied nucleotide and that the error rate of the yellow fever virus RNA polymerase employed by the chimeras for genome replication in infected cells was as low as 1.9 x 10-7 to 2.3 x 10-7. Clustering of beneficial mutations that accumulated after multiple virus passages suggests that the N-terminal part of the prM protein, a specific site in the middle of the E protein, and the NS4B protein may be essential for nucleocapsid-envelope interaction during flavivirus assembly.


* Corresponding author. Mailing address: Acambis, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 761-4200. Fax: (617) 494-1741. E-mail: tom.monath{at}acambis.com.

{dagger} Present address: DynPort Vaccine Co., LLC, Frederick, MD 21702.


Journal of Virology, January 2004, p. 1032-1038, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.1032-1038.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Anez, G., Men, R., Eckels, K. H., Lai, C.-J. (2009). Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques. J. Virol. 83: 10384-10394 [Abstract] [Full Text]  
  • Leung, J. Y., Pijlman, G. P., Kondratieva, N., Hyde, J., Mackenzie, J. M., Khromykh, A. A. (2008). Role of Nonstructural Protein NS2A in Flavivirus Assembly. J. Virol. 82: 4731-4741 [Abstract] [Full Text]  
  • Orlinger, K. K., Hoenninger, V. M., Kofler, R. M., Mandl, C. W. (2006). Construction and Mutagenesis of an Artificial Bicistronic Tick-Borne Encephalitis Virus Genome Reveals an Essential Function of the Second Transmembrane Region of Protein E in Flavivirus Assembly. J. Virol. 80: 12197-12208 [Abstract] [Full Text]  
  • Leyssen, P., De Clercq, E., Neyts, J. (2006). The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication. Mol. Pharmacol. 69: 1461-1467 [Abstract] [Full Text]  
  • Attoui, H., Jaafar, F. M., Belhouchet, M., Tao, S., Chen, B., Liang, G., Tesh, R. B., de Micco, P., de Lamballerie, X. (2006). Liao ning virus, a new Chinese seadornavirus that replicates in transformed and embryonic mammalian cells. J. Gen. Virol. 87: 199-208 [Abstract] [Full Text]  
  • Attoui, H., Jaafar, F. M., Belhouchet, M., Aldrovandi, N., Tao, S., Chen, B., Liang, G., Tesh, R. B., de Micco, P., de Lamballerie, X. (2005). Yunnan orbivirus, a new orbivirus species isolated from Culex tritaeniorhynchus mosquitoes in China. J. Gen. Virol. 86: 3409-3417 [Abstract] [Full Text]  
  • Helt, A.-M., Harris, E. (2005). S-Phase-Dependent Enhancement of Dengue Virus 2 Replication in Mosquito Cells, but Not in Human Cells. J. Virol. 79: 13218-13230 [Abstract] [Full Text]  
  • Furio, V., Moya, A., Sanjuan, R. (2005). The cost of replication fidelity in an RNA virus. Proc. Natl. Acad. Sci. USA 102: 10233-10237 [Abstract] [Full Text]  
  • Poole, A. M., Logan, D. T. (2005). Modern mRNA Proofreading and Repair: Clues that the Last Universal Common Ancestor Possessed an RNA Genome?. Mol Biol Evol 22: 1444-1455 [Abstract] [Full Text]  
  • Gehrke, R., Heinz, F. X., Davis, N. L., Mandl, C. W. (2005). Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J. Gen. Virol. 86: 1045-1053 [Abstract] [Full Text]  
  • Guirakhoo, F., Zhang, Z., Myers, G., Johnson, B. W., Pugachev, K., Nichols, R., Brown, N., Levenbook, I., Draper, K., Cyrek, S., Lang, J., Fournier, C., Barrere, B., Delagrave, S., Monath, T. P. (2004). A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys. J. Virol. 78: 9998-10008 [Abstract] [Full Text]  
  • Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., Brown, N., Brandler, S., Fournier, C., Barrere, B., Rizvi, F., Travassos, A., Nichols, R., Trent, D., Monath, T. (2004). Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates. J. Virol. 78: 4761-4775 [Abstract] [Full Text]